Share on StockTwits
 

Equities researchers at Goldman Sachs assumed coverage on shares of Omega Healthcare Investors (NYSE: OHI) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.

The analysts wrote, “We are initiating coverage of Omega Healthcare (OHI) with a Buy rating, relative to our Attractive healthcare coverage view, and we add the shares to the Americas Conviction List. We have a 12-month price target of $41 (51% upside including dividends). We believe a wide spread between acquisition yields and corporate cost of capital and a smaller current earnings base will support robust earnings growth despite limited contractual rent growth. We estimate that OHI’s projected six-year AFFO growth of 99% will be the 4th highest in all of our coverage. In addition, we think that OHI should be able to weather the current government reimbursement environment with minimal impact to its business given current in-place coverage levels and lease durations.”

Shares of Omega Healthcare Investors (NYSE: OHI) traded up 1.05% during mid-day trading on Thursday, hitting $28.83. Omega Healthcare Investors has a one year low of $20.14 and a one year high of $28.84. The stock’s 50-day moving average is currently $27.48. The company has a market cap of $3.257 billion and a P/E ratio of 25.47.

A number of other analysts have also recently weighed in on OHI. Analysts at Zacks upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating in a research note to investors on Tuesday, February 19th. They now have a $30.10 price target on the stock. Analysts at Jefferies Group raised their price target on shares of Omega Healthcare Investors from $24.00 to $26.00 in a research note to investors on Thursday, February 14th.

Omega Healthcare Investors, Inc. is a self-administered real estate investment trust (NYSE: OHI), investing in income-producing healthcare facilities, long-term care facilities located in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.